Skip to content

Effect of lactic acid bacteria Rosell-11&52 on vaginal bacterial flora

Effect of lactic acid bacteria Rosell-11&52 on vaginal bacterial flora

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030210147
Enrollment
15
Registered
2021-06-14
Start date
2021-11-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of vaginal bacterial flora

Interventions

Take 3 "lactic acid bacteria Rosell-11&52" daily, in principle, after each meal. If you cannot take it after each meal, you may take it all at once.

Sponsors

Endo Toshiaki
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Those who voluntarily express their participation in the examination and who meet the following selection criteria and do not violate the exclusion criteria are eligible. (1) Women who have menstruation between the ages of 20 and 50 at the time of obtaining consent (2) Those who can cooperate with the pre-questionnaire (3) Receive an explanation of the clinical trial in advance, understand the content, agree with the purpose, and obtain the written consent of the person.

Exclusion criteria

Exclusion criteria: (1) Those who are going to the hospital due to uterine and vaginal diseases (2) Those who are taking antibiotics and antibacterial agents (within 1 month) (3) Those who are taking hormones (4) Those who are breastfeeding (5) Those who are taking lactic acid bacteria / lactoferrin supplements (within 1 month) (6) Persons with a history of serious illnesses such as heart, liver, kidneys, digestive organs, etc. (7) Heavy alcohol drinkers (8) Persons with extremely irregular eating habits, persons with irregular life rhythms such as shift workers and late-night workers (9) Those who are allergic to drugs and foods (10) Those who are participating in clinical trials of other medicines or health foods, those who are within 4 weeks after the end of the trial, or those who plan to participate in other clinical trials after consenting to participate in this trial. (11) Others who are judged to be inappropriate for this test (12) Persons who work for cosmetics, pharmaceuticals, and hygiene products companies in person or in the family

Design outcomes

Primary

MeasureTime frame
Balance of vaginal flora

Secondary

MeasureTime frame
Subjective symptoms related to vaginal discharge (smelling, graying, smoothness, etc.) and subjective symptoms such as mild itching and swelling in the vulva (questionnaire)

Contacts

Public ContactYusuke Ishikawa

FamiOne , Inc.

y-ishikawa@famione.com+81-80-2243-6995

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026